AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$5.81 USD
+0.03 (0.52%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.80 -0.01 (-0.17%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
ANGO 5.81 +0.03(0.52%)
Will ANGO be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ANGO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ANGO
AngioDynamics (ANGO) Q3 Earnings and Revenues Miss Estimates
AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment
ANGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
AngioDynamics (ANGO) Settles Patent Litigations With BD
Analysts Estimate AngioDynamics (ANGO) to Report a Decline in Earnings: What to Look Out for
AngioDynamics (ANGO) Declines More Than Market: Some Information for Investors
Other News for ANGO
Insiders Buying Zumiez And 3 Other Stocks
A Leaner AngioDynamics Is A High-Risk Execution-Driven Story
Buy Rating Affirmed for AngioDynamics Amid Strong Sales and Strategic Growth Opportunities
Biggest stock mover today: GCTS, TSVT, GRIN, ANGO, ATUS, and more
Check-Cap, Outset Medical, Vincerx Pharma among healthcare movers